Savella (Allergan, Inc.)
Welcome to the PulseAid listing for the Savella drug offered from Allergan, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan, Inc. |
NON-PROPRIETARY NAME: | milnacipran hydrochloride |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-04-17 |
END MARKETING DATE: | 0000-00-00 |
Savella HUMAN PRESCRIPTION DRUG Details:
Item Description | Savella from Allergan, Inc. |
LABELER NAME: | Allergan, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2009-04-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0456-1500_9be3490c-8b90-40ae-aca0-e56863f1ef0c |
PRODUCT NDC: | 0456-1500 |
APPLICATION NUMBER: | NDA022256 |